SIDT2
SID1 transmembrane family member 2
Also known as: CGI-40, SIDT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBJ9
- Gene
- SIDT2
- Ensembl
- ENSG00000149577
- Chromosome
- 11
- Canonical length
- 832 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable several functions, including AP-1 adaptor complex binding activity; AP-2 adaptor complex binding activity; and RNA transmembrane transporter activity. Involved in RNA transport. Located in lysosomal membrane and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
832 residues, UniProt reviewed canonical sequence.
>Q8NBJ9|SIDT2
1 MFALGLPFLV LLVASVESHL GVLGPKNVSQ KDAEFERTYV DEVNSELVNI YTFNHTVTRN
61 RTEGVRVSVN VLNKQKGAPL LFVVRQKEAV VSFQVPLILR GMFQRKYLYQ KVERTLCQPP
121 TKNESEIQFF YVDVSTLSPV NTTYQLRVSR MDDFVLRTGE QFSFNTTAAQ PQYFKYEFPE
181 GVDSVIVKVT SNKAFPCSVI SIQDVLCPVY DLDNNVAFIG MYQTMTKKAA ITVQRKDFPS
241 NSFYVVVVVK TEDQACGGSL PFYPFAEDEP VDQGHRQKTL SVLVSQAVTS EAYVSGMLFC
301 LGIFLSFYLL TVLLACWENW RQKKKTLLVA IDRACPESGH PRVLADSFPG SSPYEGYNYG
361 SFENVSGSTD GLVDSAGTGD LSYGYQGRSF EPVGTRPRVD SMSSVEEDDY DTLTDIDSDK
421 NVIRTKQYLY VADLARKDKR VLRKKYQIYF WNIATIAVFY ALPVVQLVIT YQTVVNVTGN
481 QDICYYNFLC AHPLGNLSAF NNILSNLGYI LLGLLFLLII LQREINHNRA LLRNDLCALE
541 CGIPKHFGLF YAMGTALMME GLLSACYHVC PNYTNFQFDT SFMYMIAGLC MLKLYQKRHP
601 DINASAYSAY ACLAIVIFFS VLGVVFGKGN TAFWIVFSII HIIATLLLST QLYYMGRWKL
661 DSGIFRRILH VLYTDCIRQC SGPLYVDRMV LLVMGNVINW SLAAYGLIMR PNDFASYLLA
721 IGICNLLLYF AFYIIMKLRS GERIKLIPLL CIVCTSVVWG FALFFFFQGL STWQKTPAES
781 REHNRDCILL DFFDDHDIWH FLSSIAMFGS FLVLLTLDDD LDTVQRDKIY VFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIDT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 109 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 109 nTPM
- stomach: 71 nTPM
- ovary: 59 nTPM
- prostate: 47 nTPM
- duodenum: 42 nTPM
- small intestine: 40 nTPM
Single-cell type
- pancreatic acinar cells: 97 nCPM
- kupffer cells: 94 nCPM
- goblet cells: 85 nCPM
- foveolar cells: 69 nCPM
- extravillous trophoblasts: 67 nCPM
- adipocytes: 62 nCPM
Immune cell
- non-classical monocyte: 152 nTPM
- intermediate monocyte: 84 nTPM
- naive B-cell: 21 nTPM
- memory B-cell: 18 nTPM
- classical monocyte: 14 nTPM
- myeloid DC: 12 nTPM
Brain region
- white matter: 91 nTPM
- medulla oblongata: 70 nTPM
- pons: 60 nTPM
- spinal cord: 55 nTPM
- midbrain: 53 nTPM
- thalamus: 53 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.95
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell morphogenesis
- glucose homeostasis
- regulation of insulin secretion involved in cellular response to glucose stimulus
- response to glucose
- RNA catabolic process
- RNA transport
- type B pancreatic cell development
- type B pancreatic cell proliferation
Molecular functions
- AP-1 adaptor complex binding
- AP-2 adaptor complex binding
- DNA binding
- double-stranded RNA binding
- RNA transmembrane transporter activity
- nucleic acid transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIDT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIDT2 as an antibody target. Whether an autoantibody or antibody against SIDT2 could matter depends on whether native SIDT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIDT2 is annotated at the cell surface, where native SIDT2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIDT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...